Nothing would change as to the partnerships we currently have and they will produce revenue. The potential of having therapeutics would decrease but Dr. Moro is pretty far along in that area so the other employees of Pacific BioSciences could probably carry out the process. As far as someone to run the company, Wittenberg would be dead weight in that regard but Phil Gold would be able to hire a successor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.